CURRICULUM VITAE M.Sc. in Medical Virology, Tarbiat Modarres University, Tehran, Iran.
|
|
|
- Della Mitchell
- 5 years ago
- Views:
Transcription
1 CURRICULUM VITAE Fatemeh Fotouhi Ph.D in Medical Virology Associate Proffessor Influenza and other Respiratory Viruses Pasteur Institute of Iran, Tehran, Iran. Phone #: +98 (21) Fax #: +98 (21) Cell #: fotouhi@pasteur.ac.ir, fotouhi44@yahoo.com Education: Postdoctoral fellow in Queen s University, Department of Microbiology and Immunology, Kingston, Canada Ph.D. in Medical Virology, Tarbiat Modarres University, Tehran, Iran M.Sc. in Medical Virology, Tarbiat Modarres University, Tehran, Iran B.Sc. in Microbiology, Tehran University, Tehran, Iran. Honors and Awards: 2006 First ranked among PhD students, Tarbiat Modarres University Second Prize Winner, Young Researcher, In 4th Razi Festival, Winter 1998, Tehran First ranked in M.Sc. Entrance Exam, Tarbiat Modarres University. Employment History: 2008-now Assistant Professor, Virology Dept, Pasteur Institute of Iran Research assistant, full time. Assisted post-graduated students in their projects Training in Research Department, Minstry of Health M.Sc. student, full time Biology & Chemistry laboratory instructor in State High School 1
2 Research project director: 1) construction of a chimerical expression vector carrying influenza virus M2 protein and HSP70 gene and protein expression in COS-7 and/or HEK 293 cells (2010) 2) Production of M2-HSP70 chimeric protein containing influenza virus M2 protein and Leishmania Major HSP70 in prokaryotic system (E.coli) and assessment of its immunogenicity in mice (2012) 3) Application of Multiplex Real Time PCR in order to detect respiratory viruses in clinical samples collected from acute respiratory infected patients Research project co-worker: 1) Expression of Human Influenza Hemagglutinin in BES (Baculovirus Expression System) for subunit vaccine production 2) Molecular analysis of influenza A virus "amantadine" resistance in Pediatric Infectious Research Center's outpatients during Fall and Winter of ) Virosome construction from Influenza virus to include Nucleoprotein gene as DNA vaccine against the virus 4) Suspending MDCK cell line for large scale culture of influenza virus 5) Establishment and application of RT-PCR & Real Time PCR assays to identify influenza virus 6) Influenza Virus detection and identification 7) Construction of H1N1 Influenza virus like particle containing HA and M1 proteins based on baculoviral system 8) Construction of H5N1 Influenza virus like particle 9) Construction of swine H1N1 Influenza virus like particle Professional Activities: present Member of Iranian Society of Virology Workshops (co-chairman): Virology Symposium, held by Iranian Siciety of Virology, Pasteur Institute of Iran, 2013 The Sixth Summer School, Pasteur Institute of Iran, Influenza Lab Research, 2015 The Fifth Summer School, Pasteur Institute of Iran, Influenza Lab Research, 2014 The Forth Summer School, Pasteur Institute of Iran, Influenza Lab Research,
3 The Third Summer School, Pasteur Institute of Iran, Influenza Lab Research, 2012 The Second Summer School, Pasteur Institute of Iran, Influenza Lab Research, 2011 The First Summer School, Pasteur Institute of Iran, Influenza Lab Research, 2010 Books: "Baculoviruses and Insect cells as powerful tools for gene expression" published by Tehran Jahad, Tehran. I.R, 2009 "Molecular cloning & Expression of recombinant protein" published by Tarbiat Modares University, School of Medical Sciences. Tehran I. R. IRAN Publications (Articles): 1. Kianmehr, zahra; Kaboudanian Ardestani, Susan; soleimanjahi, hoorieh; Farahmand, Behrokh; abdoli, asghar; Khatami, Maryam; Akbari, Khadijeh; Fotouhi, Fatemeh*, An effective DNA priming-protein boosting approach for the cervical cancer vaccination, FEMS Pathogens and Disease, 73(2): Kianmehr Z, Ardestani SK*, Soleimanjahi H, Fotouhi F. Comparison of Biological and Immunological Characterization of Lipopolysaccharides from Brucella abortus RB51 and S19, Jundishapur J Microbiol. 2015, 3. Kianmehr Z, Soleimanjahi H*, Ardestani SK, Fotouhi F, Abdoli A. Influence of Brucella abortus lipopolysaccharide as an adjuvant on the immunogenicity of HPV-16 L1VLP vaccine in mice. Med Microbiol Immunol, 2015 Apr;204(2): Fatemeh Fotouhi*, Behrokh Farahmand, Behnaz Heidarchi, Maryam Esghaei, Sima Rafati, Masoumeh Tavassoti Kheiri. In Vitro Evaluation of Influenza M2 and Leishmania major HSP70 ( ) Chimer Protein. JJM 2014 September; 7(9): 5. Azadeh Sajadian, Alijan Tabarraei, Hoorieh Soleimanjahi, Fatemeh Fotouhi, Ali Gorji, Amir Ghaemi*, Comparing the effect of Toll-like receptor agonist adjuvants on the efficiency of a DNA vaccine. Arch Virol 2014, 6. Siavash chalabiani, Fatemeh Fotouhi*, Mmaryam Saleh, Mansoureh Tabatabaian, Behrokh Farahmand, Mohammad ali Alavi Esfahani, Ali Torabi. Prokaryotic production of Influenza Virus M2 protein fused to Leishmania major HSP70 in order to prepare an effective flu vaccine. Journal of Isfahan Medical School. 2014, 32(288):
4 7. Z. Yosefi najafabadi, F. Behzadian*, F. Fotouhi, B. Farahmand, M. Tat. Prokaryotic expression of influenza A virus nucleoprotein fused to mycobacterial heat shock protein 70. Iranian journal of virology.2013;7(1&2) Seyedeh Fahime Mousavi, Fatemeh Fotouhi*, Atena Yousefi, Behrokh Frarahmand, Behnaz Heydarchi, Rezvan Tavakoli, Masoumeh Tavassoti Kheiri. Isolation and fulllength characterization of a novel Influenza Virus A hemagglutinin from 2009 pandemic Flu. ISMJ 2014; 17(2): Seyedeh Fahime Mousavi, Masoumeh Tavassoti Kheiri, Seyed Masoud Hosseini*, Mojgan Taghizadeh, Fatemeh Fotouhi, Behnaz Heydarchi, Rouzbeh Bashar, Hosna Gomari, Phylogenetic Comparison of Influenza Virus Isolates from Three Medical Centers in Tehran with the Vaccine Strains during , IJMS 2011(36): Mousavi SF, Tavassoti-Kheiri M*, Taghizadeh M, Fotouhi F, Heydarchi B, Tabatabaiean M, Partial Quality Control of Inactivated Split Human Influenza Vaccine Iranian Journal of Virology 2012;6(2): Abdoli A, Soleimanjahi H*, Fotouhi F, Teimoori A, Pour Beiranvand S, Kianmehr Z. Human Papillomavirus Type16- L1 VLP Production in Insect Cells. Iran J Basic Med Sci. 2013, Aug; 16(8): Tavakoli R, Fotouhi F*, Tavassoti-Kheiri M, Farahmand B, Saleh M, Tabatabaeiyan M. Expression of Influenza Heamagglutinin Globular Head in Different Eukaryotic Cells. Iranian Journal of Virology 2012;6(1): Alavi Esfahani MA, Fotouhi F*, Ghaemi A, Saleh M, Chalabiani S, Farahmand B, TavasotiKheiri M. Expression of M2 Protein of Human Influenza Virus (H1N1) In E. coli. Journal of Isfahan Medical School. 2013, 30(216): Farida Behzadian*, Zahra Goodarzi, Fatemeh Fotouhi Chahooki, Esmaiel Saberfar. Baculoviral co- expression of HA, NA and M1 proteins of highly pathogenic H5N1 influenza virus in insect cells. Jundishapur Journal of Microbiology, (In Press) 15. Rousta F, Fotouhi F*, Ghaemi A, Heidarchi B, Mazaheri V, Fazeli M, Torabi A, Ghaffari M. Effects of Echinacea purpurea extract on immunogenicity of DNA vaccine encoding M2 gene of Influenza virus. Journal of Gorgan University of Medical Sciences. 2013, 14(4):
5 16. Najafi S, Behzadian F*, Fotouhi Chahooki F, Fallah Mehrabadi J. Construction of a recombinant bacmid DNA in order to express neuraminidase gene of influenza virus H1N1. Arak Medical University Journal (AMUJ) 2012; 15(64): Seyedeh Fahime Mousavi, Fatemeh Fotouhi*, Atena Yousefi, Behrokh Frarahmand, Behnaz Heydarchi, Rezvan Tavakoli, Masoumeh Tavassoti Kheiri. Isolation and fulllength characterization of a novel Influenza Virus A hemagglutinin from 2009 pandemic Flu. Iranian south medical journal (In Press) 18. Hossainzadeh S, Fotouhi F*, Farahmand B, Saleh M, Yousefi A, Heydarchi B, Kheiri MT. Construction of recombinant bacmid DNA encoding influenza virus A(H1N1) hemagglutinin gene. Modares Journals of Medical Sciences: Pathobiology, 2012, 14(4): Esghaei M, Monavari SH*, Tavassoti-Kheiri M, Shamsi-Shahrabadi M, Heydarchi B, Farahmand B, Saleh M, Fotouhi F. Expression of the influenza M2 protein in three different eukaryotic cell lines, J Virol Methods Jan; 179(1): Yousefi A, Fotouhi F*, Hosseinzadeh S, Kheiri MT, Farahmand B, Mousavi F, Mousavi F. Expression of Antigenic Determinant of Haemagglutinin Large Subunit of Novel Influenza Virus in Insect Cells, Folia Biologica (Praha), 2012, (58): Shahsavandi S, Salmanian A*, Ghorashi SA, Masoudi S, Fotouhi F, Ebrahimi MM. Development of rha1-elisa for specific and sensitive detection of H9 subtype influenza virus. J Virol Methods, 2011; 171(1): Shahsavandi S, Salmanian A*, Ghorashi SA, Masoudi S, Fotouhi F, Ebrahimi MM. Specific subtyping of influenza A virus using a recombinant hemagglutinin protein expressed in baculovirus, Mol Biol Rep Jun;38(5): Farahmand B, Khodabandeh M, Mahboudi F, Fotouhi F, Saleh M, Barkhordari F, Tabatabaian M, Parsaie Nasab F, Kheiri T M*. The Influenza virus hemagglutinin: a model for protein N-glycosylation in recombinant Escherichia coli, Intervirology, 2012, 55(3): Farahmand B, Khodabandeh M, Mahboudi F, Fotouhi F, Barkhordari F, Saleh M, Kheiri T M*. Isolation, cloning, and sequencing of influenza A (H1N1) hemagglutinin for production of hemagglutinin gene bank. Arak Medical University Journal (Rahavard Danesh), 2011; 13(4):
6 25. B Heydarchi, SM Hosseini*, M Tavassoti-Kheiri, N Sheykhi, SF Mousavi, R Khaltabadi-Farahani, R Bashar, F Fotouhi, T Bolurieh, Evidence of H1 and H3 Influenza Virus Infection in Captive Birds in Tehran from November 2008 to February 2009, Iranian Journal of Virology 2010;4(2): Z Salmani, Farida Behzadian*, Fatemeh Fotouhi-Chahooki. Construction of a Recombinant Bacmid DNA to Express Influenza Virus Matrix Protein1 (M1) in Insect Cell Line, Iranian Journal of Virology 2010; 4(1): H Razavi-Nikoo, H Soleimanjahi*, F Fotouhi, A Ghaemi, M Fazeli. Construction of the Chimeric HSP70 - E7 Vector and Evaluation of its Protein Production, Iranian Journal of Virology 2009;3(3): Ali Teimoori, Hoorieh Soleimanjahi*, Fatemeh Fotouhi, Zahra Meshkat. Isolation and cloning of human papillomavirus 16 L1 gene from Iranian isolate. Saudi Med J 2008; 29 (8): Fotouhi Fatemeh., Soleimanjahi Hoorieh*. Roostaee Mohammad Hasan and Dalimi Asl Abdolhossein. Expression of the Herpes Simplex Virus Type 2 Glycoprotein D in Baculovirus Expression System and Evaluation of Its Immunogenicity in Guinea pigs. Iranian Biomedical Journal 2008, 12(2): Fotouhi Fatemeh., Soleimanjahi Hoorieh*, Roostaee Mohammad Hasan, and Behzadian Farida. Enhancement of protective humoral immune responses against herpes simplex virus-2 in DNA-immunized guinea pigs using protein boosting. FEMS Immunol Med Microbiol. 2008, 54: Mohammad Jazayeri Farsani, Hoorieh Soleimanjahi*, Fatemeh Fotouhi, and Nafiseh Pakravan. Comparison of Intramuscular and Footpad Subcutaneous Immunization with DNA Vaccine Encoding HSV- gd2 in Mice. Comparative Immunology, Microbiology and Infectious Diseases, 2009, 32: Behzadian F, Sabahi F*, Sadeghizadeh M, Maghsoodi N, Fotouhi F. and Karimi M. In vitro replication of Hepatitis D Virus using a new construct containing a cdna dimer of HDV genome. Intervirology 2007, 50: Mohammad Jazayeri Farsani, Hoorieh Soleimanjahi*, Fatemeh Fotouhi, Taravat Bamdad, Abbas Jamali. Evaluation of cross immune response in DNA based vaccinated mice against HSV-1 and HSV-2. Gene Therapy & Molecular Biology, 2007, (11):
7 34. H. Soleimanjahi, F. Fotouhi, T. Bamdad. MH. Roostaee*, Evaluation of HI antibodies against rubella virus to determine the immune status, regarding the mass campaign vaccination in Tehran, Iran, Iranian Journal of Virology, 2007, (1), Marzieh Jamalidoost, Hoorieh Soleimanjahi*, Fatemeh Fotouhi and Zahra Meshkat. Amplification and Cloning of Herpes Simplex Virus Type 2 Glycoprotein- G from an Iranian Isolate. Pakistan Journal of Biological science. 2007,10(6): Soleimanjahi H, Bamdad T, Fotouhi F, Roostaee MH*, Faghihzadeh S. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran. J Clin Virol. 2005, 34(2): Fotouhi Chahooki, F., Roostaee*, M. H., Soleimanjahi. H and Haqshenash, G. R. Construction of an Eukaryotic Expression Vector Encoding Herpes Simplex Virus Type 2 Glycoprotein D (gd2) and In Vitro Expression of the Desired protein. Arch.Razi. 2005(59), Fotouhi F., Roustaee* M.H., Khabiri A.R., Soleimanjahi H., Malekane M., and F.Sabahi. Application of Dot Immunoassay for Detection and Titration of Measles Virus Antibodies. Med.J. of the IR.IRAN 2001, 15(1): Reviewer for journals PLoS ONE African Journal of Microbiology Reaearch Brazilian Journal of Microbiology African Journal of Biotechnology Joundishapoor Journal of Microbiology (associate edittor) Cell Journal (yakhte) Iranian Biomedical Journal Iranian Journl of virology Daneshvar Journal Iranian Journal of Biotechnology Iranian Journal of Immunology Modares Journl of medical sciences 7
Postdoctoral fellow in Queen s University, Department of M icrobiology and
CURRICULUM VITAE Name: Fatemeh Fotouhi Date of birth: Jan. 13, 1966 Place of birth: Iran,Tehran Marital Status: Married, 2 children Address: Influenza unit, Department of Virology, Pasteur Institute of
Fogerite S.; Targeting immune response induction with cochleate and liposome-based vaccines; Adv Drug Deliv Rev Jul 6;32(3):
1. Kheiri, M.T., Edghill-Smith, Y., Das, K., Wang, Z., Feketeova, E., Mannino, R.J., and Gould-Fogerite, S., The use of cochleate-based subunit influenza vaccines to elucidate the regulation of mucosal
Curriculum Vitae of Dr. Rouzbeh Bashar
Curriculum Vitae of Dr. Rouzbeh Bashar Feb. 18th 2012 First name: Rouzbeh Second Name: Bashar Date of Birth: Sept. 28 th 1962 Place of Birth: Tehran Iran Nationality: Iranian Marital Status: Married Gender:
The humoral immune responses to IBV proteins.
The humoral immune responses to IBV proteins. E. Dan Heller and Rosa Meir The Hebrew University of Jerusalem, Israel COST FA1207 meeting WG2 + WG3, Budapest, Jan. 2015 1 IBV encodes four major structural
Cover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/35908 holds various files of this Leiden University dissertation Author: Soema, Peter Title: Formulation of influenza T cell peptides : in search of a universal
Min Levine, Ph. D. Influenza Division US Centers for Disease Control and Prevention. June 18, 2015 NIBSC
Workshop on Immunoassay Standardization for Universal Flu Vaccines Min Levine, Ph. D. Influenza Division US Centers for Disease Control and Prevention June 18, 2015 NIBSC 1 Multiple Immune Mechanisms Contribute
Original Article. Maryam Fazeli 1, Hoorieh Soleimanjahi 1, Simin Dadashzadeh 2
Original Article Further Stimulation of Cellular Immune Responses through Association of HPV-16 E6, E7 and L1 Genes in order to produce more Effective Therapeutic DNA Vaccines in Cervical Cancer Model
Human Influenza. Dr. Sina Soleimani. Human Viral Vaccine Quality Control 89/2/29. November 2, 2011 HVVQC ١
Human Influenza Dr. Sina Soleimani Human Viral Vaccine Quality Control 89/2/29 November 2, 2011 HVVQC ١ Presentation outline 1. Introduction 2. Virology 3. Classification 4. Hosts 5. Antigenic Specifications
VIROLOGY OF INFLUENZA. Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks
INFLUENZA VIROLOGY OF INFLUENZA Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks PATHOGENICITY High pathogenicity avian influenza (HPAI) Causes severe disease in poultry
100 years of Influenza Pandemic and the prospects for new influenza vaccines
100 years of Influenza Pandemic and the prospects for new influenza vaccines Dr John McCauley Director, WHO Collaborating Centre for Reference and Research on influenza The Francis Crick Institute London
Correlates of Protection for Flu vaccines and Assays Overview. by Simona Piccirella, PhD Chief Executive Officer
Correlates of Protection for Flu vaccines and Assays Overview by Simona Piccirella, PhD Chief Executive Officer Company Overview: VisMederi is an Italian private small enterprise established in 2009 and
PATH Influenza Vaccine Projects
PATH Influenza Vaccine Projects Overview John W. Boslego, MD John Boslego Director, Vaccine Development Global Program March 25 th, 2014 Influenza Vaccine Project (IVP) at PATH IVP Goal: Advance the development
Original Article Expression of Antigenic Determinants of the Haemagglutinin Large Subunit of Novel Influenza Virus in Insect Cells
Original Article Expression of Antigenic Determinants of the Haemagglutinin Large Subunit of Novel Influenza Virus in Insect Cells (haemagglutinin / Bacmid / baculovirus) A.Yousefi 1, F. Fotouhi 2, S.
Challenges in Vaccine Production and Rapid Scale up to Meet Emerging Pandemic Threats
Challenges in Vaccine Production and Rapid Scale up to Meet Emerging Pandemic Threats Susan Dana Jones, Ph.D. BioProcess Technology Consultants, Inc. BIO 2009 Process Zone Theater Atlanta, GE May 20, 2009
Studying Repeated Immunization in an Animal Model. Kanta Subbarao Laboratory of Infectious Diseases, NIAID
Studying Repeated Immunization in an Animal Model Kanta Subbarao Laboratory of Infectious Diseases, NIAID Animal models in Influenza Research Commonly used Mice Ferrets Guinea pigs Non human primates Less
Influenza 2009: Not Yet The Perfect Storm
Influenza 2009: Not Yet The Perfect Storm What s needed for a pandemic strain? Novel virus (little to no immunity) Capable of causing disease in humans Highly pathogenic / virulent Capable of sustained
Evolution of influenza
Evolution of influenza Today: 1. Global health impact of flu - why should we care? 2. - what are the components of the virus and how do they change? 3. Where does influenza come from? - are there animal
Parvaneh Mehrbod Date of birth: Previous Address: Current Address: Mobile number: Field of expertise: Education: PhD: M.Sc: B.
Parvaneh Mehrbod Date of birth: April 28, 1976 Previous Address:Laboratory of vaccine and immunotherapeutic, Institute of Bioscience, Universiti Putra Malaysia, UPM Serdang, 43400, Selangor, Malaysia Current
Existence of reassortant A (H1N2) swine influenza viruses in Saitama Prefecture, Japan
International Congress Series 1263 (2004) 749 753 Existence of reassortant A (H1N2) swine influenza viruses in Saitama Prefecture, Japan Shin ichi Shimada a, *, Takayasu Ohtsuka b, Masayuki Tanaka b, Munehito
Complementary Course in Advance Methods of Molecular Biology , Bristol UK
Education: Complementary Course in Advance Methods of Molecular Biology. 2005-2006, Bristol UK PhD In Medical Immunology. Tarbiat Modarres University, 2006. Tehran, Iran. Diploma of The Institute of Homeopathy
Clinical Trials of Pandemic Vaccines: Key Issues. John Treanor University of Rochester Rochester, NY
Clinical Trials of Pandemic Vaccines: Key Issues John Treanor University of Rochester Rochester, NY Inactivated vaccine approach Proven technology Used successfully in 1957 and 1968 Abundant efficacy data
24 26 January 2013, Hong Kong SAR, CHINA. TITLE from VIEW and SLIDE MASTER February 27, 2013
The first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses 24 26 January 2013, Hong Kong SAR, CHINA 1 TITLE
CURRICULUM VITAE Position: Date of Birth Place of Birth: Gender Marital Status: Nationality: Address: OFFICE: Education: Training: Language:
CURRICULUM VITAE Ali Nour Nematollahi, MSc. Position: Research co-worker, Mycobacteriology Center, Institute Pasteur of Iran Date of Birth: February 6, 1963 Place of Birth: Tehran Gender: male Marital
High-Technology Route To Virus Vaccines READ ONLINE
High-Technology Route To Virus Vaccines READ ONLINE If you are searching for a book High-Technology Route to Virus Vaccines in pdf form, in that case you come on to the loyal website. We presented the
Acute respiratory illness This is a disease that typically affects the airways in the nose and throat (the upper respiratory tract).
Influenza glossary Adapted from the Centers for Disease Control and Prevention, US https://www.cdc.gov/flu/glossary/index.htm and the World Health Organization http://www.wpro.who.int/emerging_diseases/glossary_rev_sept28.pdf?ua=1
For the control of avian influenza
OIE Regional Expert Group Meeting for the Control of Avian influenza in Asia Sapporo, 3-5 October 2017 For the control of avian influenza Hiroshi Kida Hokkaido University Research Center for Zoonosis Control
A Universal Manufacturing Platform For Vaccine Production
A Universal Manufacturing Platform For Vaccine Production Manon M.J. Cox 18Mar2013 Topics The Company Baculovirus Technology Platform (BEVS) Flublok and Pandemic Influenza Other vaccines opportunities
Original Article Development and Sequence Analysis of a Cold-Adapted Strain of Influenza A/New Caledonia/20/1999(H1N1) Virus
Iranian Journal of Virology 2011;5(4): 6-10 2011, Iranian Society for Virology Original Article Development and Sequence Analysis of a Cold-Adapted Strain of Influenza A/New Caledonia/20/1999(H1N1) Virus
Transforming The Approach to Vaccines and Protein- Based Therapeutics. Alain Doucet, Ph.D. Manager, Process Development, Medicago
Transforming The Approach to Vaccines and Protein- Based Therapeutics Alain Doucet, Ph.D. Manager, Process Development, Medicago 2018-08-15 1 Medicago Overview 2 Novel Technologies 3 Robust Pipeline 2
Key 'Words: Newcastle disease virus, molecular biology, diagnostics, vaccines, biotechnology
SCiences Characterization of Newcastle Disease Virus KhatiJah Yueoff, Alnllderifi, AI7c1ulManaf All, AI7c1ullahSipat. Wen Slang Tan, Al7c:1ulRahman Omar Department of Biochemistryand Microbiology, FacultyScience
Flu, Avian Flu and emerging aspects (H1N1 resistance)
EU-CIS Seminar New trends in Infectious Diseases 26 28 November 2008 / Lyon, France Flu, Avian Flu and emerging aspects (H1N1 resistance) Pr. Florence MORFIN FRE 3011 Université Lyon 1 - CNRS Laboratory
دکتر بهروز نقیلی استاد بیماریهای عفونی مرکس تحقیقات بیماریهای عفونی و گرمسیری پاییس 88
دکتر بهروز نقیلی استاد بیماریهای عفونی مرکس تحقیقات بیماریهای عفونی و گرمسیری پاییس 88 FLU.. How often can you escape? Three viral types are distinguished by their matrix and nucleoproteins Type Host Clinical
Running head: INFLUENZA VIRUS SEASON PREPAREDNESS AND RESPONSE 1
Running head: INFLUENZA VIRUS SEASON PREPAREDNESS AND RESPONSE 1 Electron micrograph of H1N1 Virus (CDC, 2009) Influenza Virus Season Preparedness and Response Patricia Bolivar Walden University Epidemiology
Trends in vaccinology
Trends in vaccinology Mathieu Peeters, MD Joint Conference of European Human Pharmacological Societies and Joint Conference of European Human Pharmacological Societies and 20th Anniversary of AGAH March
TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important?
TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important? AUTHORS: Joshua G. Petrie 1, Adam S. Lauring 2,3 AFFILIATIONS: 1 Department of Epidemiology, University of
Vaccinology 101 for Fellows
Vaccinology 101 for Fellows Meg Fisher, MD Medical Director, The Children s Hospital Monmouth Medical Center An affiliate of the Saint Barnabas Health Care System Long Branch, NJ Disclosures I have no
Cristina Cassetti, Ph.D.
NIAID Extramural Research Update: Recombinant Influenza Viruses and Biosafety Cristina Cassetti, Ph.D. Influenza Program Officer Division of Microbiology and Infectious Diseases NIAID Influenza virus DMID
Viral vaccines. Lec. 3 أ.د.فائزة عبد هللا مخلص
Lec. 3 أ.د.فائزة عبد هللا مخلص Viral vaccines 0bjectives 1-Define active immunity. 2-Describe the methods used for the preparation of attenuated live & killed virus vaccines. 3- Comparison of Characteristics
Avian influenza and pandemic threats
Avian influenza and pandemic threats Philippe BUCHY MD, PhD Head of Virology Unit Director NIC Cambodia Vaccinology 2013 Bangkok, 11-13 November 2013 Influenza viruses Influenza viruses (Orthomyxoviridae)
Kinetics of Primary and Memory Cytotoxic. T Lymphocyte Responses to Herpes. Simplex Virus 1 Infection: Granzyme B. Mediated CTL Activity
ISSN 1735-1383 Iran. J. Immunol. March 2009, 6 (1), 22-27 Masumeh Gorgian Mohammadi, Taravat Bamdad, Masoud Parsania, Hamid Reza Hashemi, Somayeh Puyanfard Kinetics of Primary and Memory Cytotoxic T Lymphocyte
Vaccine. Design and Manufacturing. Liting Bi. https://en.wikipedia.org/wiki/vaccine
Vaccine Design and Manufacturing Liting Bi https://en.wikipedia.org/wiki/vaccine 1 Outline Vaccine Intro. 4 Vaccine Types 2 Manufacturing Methods 2 Tests & Applications Take-home messages 2 https://www.youtube.com/watch?v=t_me5ef0ne4
Influenza or flu is a
Clinical and Research Area Infectious Diseases Influenza Virus Types A and B Influenza or flu is a respiratory illness that is caused by influenza viruses. Influenza viruses type A and type B cause seasonal
Broadly protective influenza vaccines for pandemic preparedness. Suresh Mittal Department of Comparative Pathobiology Purdue University
Broadly protective influenza vaccines for pandemic preparedness Suresh Mittal Department of Comparative Pathobiology Purdue University Influenza A Virus Orthomyxovirus Consist of s/s (-) sense RNA 8 segments
CT&T (Professor Gerhard Artmann, Aachen University of Applied Sciences)
Efficacy of Bi-polar Ionization on Various Pathogens Target Substance Fungi Bacteria Species Cladosporium (black mold, mildew) Testing & Verification Organization Ishikawa Health Service Association Universitäklinikums
How does the body defend itself?
Prevention of Infection 2 Immunisation 3 rd BDS B. Martin Major World Causes Of Death COUNTRIES Developing Developed Total x10-6 Population 5400 (80%) 1200 (20%) 6600 CAUSE OF DEATH % % % Infectious diseases
UNIVERSAL INFLUENZA VIRUS VACCINES Adolfo García Sastre. Icahn School of Medicine at Mount Sinai, New York
UNIVERSAL INFLUENZA VIRUS VACCINES Adolfo García Sastre Icahn School of Medicine at Mount Sinai, New York INFLUENZA VIRUSES PAx B EPIDEMIOLOGY OF HUMAN INFLUENZA VIRUSES A H1N1 H3N2 1968 H2N2 1957 H1N1
Q: If antibody to the NA and HA are protective, why do we continually get epidemics & pandemics of flu?
Influenza virus Influenza virus Orthomyxoviridae family of viruses RNA enveloped viruses that make up three genera Influenzavirus A Influenzavirus B Influenzavirus C The type A viruses are the most virulent
Curriculum Vita. Work: Mycobacteriology Dept.of Pasteur Institute of Iran,Tehran Tel/fax: (+98) E.mail:
Curriculum Vita First Name: Farid Last Name: Abdolrahimi Date of birth: 22.03.1971 Place of Birth: Tonekabon - Iran Nationality: Iranian Position Title: M.Sc. in Mycobacteriology Dept. Address: Work: Mycobacteriology
Biotechnology-Based Vaccines. Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel:
Biotechnology-Based Vaccines Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa Objectives of this lecture By the end of this lecture you will be able to: 1.
FDA Approved Recombinant Hemagglutinin Influenza Vaccine Protects Against Drift Influenza Viruses
FDA Approved Recombinant Hemagglutinin Influenza Vaccine Protects Against Drift Influenza Viruses 2 nd International conference on Flu October 31- November 02, 2016 San Francisco, California, USA Protein
Lichenase: a versatile, stable carrier molecule for vaccine and reagent development
Lichenase: a versatile, stable carrier molecule for vaccine and reagent development R. Mark Jones Center for Molecular Biotechnology, Fraunhofer USA New Cells, New Vaccines VII, From Protein to Product
Review on vectored influenza vaccines. Sarah Gilbert Jenner Institute Oxford
Review on vectored influenza vaccines Sarah Gilbert Jenner Institute Oxford Viral Vectored Influenza Vaccines Can be used to induce antibodies against HA Will also boost CD4 + T cell responses against
CURRICULUM VITAE EDUCATION
CURRICULUM VITAE First name: Fatemeh Last name: Nadali Date of birth: 4 Jan 1961 ADD: Pathology Department School of Medicine Isfahan University of Medical Sciences Isfahan IRAN Tel: +98 311 7922475 Mobile:
Influenza Prevention Update
Influenza Prevention Update Dean A. Blumberg, MD, FAAP Disclosure speakers bureau: sanofi pasteur, Merck Discussion off label use of FDA approved vaccines Influenza Prevention Update Seasonal influenza
Likelihood that an unsubtypeable Influenza A result. in the Luminex xtag Respiratory Virus Panel. is indicative of novel A/H1N1 (swine-like) influenza
JCM Accepts, published online ahead of print on 3 June 2009 J. Clin. Microbiol. doi:10.1128/jcm.01027-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
Current Vaccines: Progress & Challenges. Influenza Vaccine what are the challenges?
Current Vaccines: Progress & Challenges Influenza Vaccine what are the challenges? Professor John S. Tam The Hong Kong Polytechnic University Asia-Pacific Alliance for the Control of Influenza (APACI)
Development of Recombinant MERS-CoV Spike (S) Nanoparticle Vaccine
Development of Recombinant MERS-CoV Spike (S) Nanoparticle Vaccine Russell P. Wilson Senior Vice President, Business Development Vaccine World MENA & CIS 2014 Istanbul, Turkey November 19, 2014 1 www.novavax.com
Influenza A(H1N1)2009 pandemic Chronology of the events in Belgium
Arch Public Health 2010, 68, 48-52 Influenza A(H1N1)2009 pandemic Chronology of the events in Belgium by Litzroth A 1, Gutiérrez I 1,2, Hammadi S 1 Keywords Belgium, chronology, epidemiology, influenza
Influenza. Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong
Influenza Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong Influenza Virus Nomenclature Influenza virus A, B & C Influenza A : Haemagglutinin (H), neuraminidase (N) A H3N2,
MEETING THE STANDARDS: FDA MANDATORY RAPID INFLUENZA DETECTION TEST (RIDTs) RECLASSIFICATION
MEETING THE STANDARDS: FDA MANDATORY RAPID INFLUENZA DETECTION TEST (RIDTs) RECLASSIFICATION NOVEMBER 6, 2017 SALLY A. HOJVAT M.Sc., Ph.D. Retired as Director of FDA Division of Microbiology Devices, CDRH
The QIAsymphony RGQ as a platform for laboratory developed tests
The QIAsymphony RGQ as a platform for laboratory developed tests James B. Mahony Ph.D., F.A.A.M., F.C.C.M. Director, Regional Virology Laboratory St. Joseph s Healthcare, Hamilton Assistant Dean Medical
Update on Influenza Vaccines, the Influenza Season, and the Impact of Vaccination on Influenza Disease Burden
National Center for Immunization & Respiratory Diseases Update on Influenza Vaccines, the 2017 2018 Influenza Season, and the Impact of Vaccination on Influenza Disease Burden Melissa Rolfes, PhD MPH Epidemiologist
Nanoparticulate Vaccine Design: The VesiVax System
Nanoparticulate Vaccine Design: The VesiVax System Gary Fujii, Ph.D. President and CEO Molecular Express, Inc. May 16, 2006 Orlando, Florida Influenza Each year up to 20% of the world's population contracts
Assessment of Influenza Vaccine Production Compatibilities
United States Department of Health & Human Services Office of the Assistant Secretary for Preparedness and Response Assessment of Influenza Vaccine Production Compatibilities Joshua Speidel, PhD Influenza
Anahita Mohseni Meybodi
Anahita Mohseni Meybodi Personal information: Surname: Mohseni- Meybodi Gender: Female First name: Anahita Marital states: Married Place of Birth: Tehran Date of Birth: 1976. July. 27 Citizenship: Iranian
TOWARDS A UNIVERSAL INFLUENZA VIRUS VACCINE
TOWARDS A UNIVERSAL INFLUENZA VIRUS VACCINE Peter Palese Icahn School of Medicine at Mount Sinai New York OPTIONS IX 8-26-16 ISIRV - Options IX for the Control of Influenza Peter Palese, PhD Professor
Reassortment of influenza A virus genes linked to PB1 polymerase gene
International Congress Series 1263 (2004) 714 718 Reassortment of influenza A virus genes linked to PB1 polymerase gene Jean C. Downie* www.ics-elsevier.com Centre for Infectious Diseases and Microbiology,
Cloning and Expression of Influenza H1N1 NS1 Protein in Escherichia Coli BL21
Iran J Biotech. 2014 March; 12(1): e12625. Published online 2014 March 19. DOI: 10.5812/ijb.12625 Research Article Cloning and Expression of Influenza H1N1 NS1 Protein in Escherichia Coli BL21 Marzieh
Influenza. By Allison Canestaro-Garcia. Disease Etiology:
Influenza By Allison Canestaro-Garcia Disease Etiology: The flu is an infectious disease caused by a subset of viruses of the family Orthomyxoviridae. There are 7 different viruses in this family, four
Original Article Polyclonal Antibody against Recombinant Nucleoprotein of the Influenza A Virus (H1N1); Production and Purification
Iranian J Virol 2017;11(2): 36-42 2017, Iranian Society of Virology. All rights reserved. Original Article Polyclonal Antibody against Recombinant Nucleoprotein of the Influenza A Virus (H1N1); Production
Palindromes drive the re-assortment in Influenza A
www.bioinformation.net Hypothesis Volume 7(3) Palindromes drive the re-assortment in Influenza A Abdullah Zubaer 1, 2 * & Simrika Thapa 1, 2 1Swapnojaatra Bioresearch Laboratory, DataSoft Systems, Dhaka-15,
Influenza. Tim Uyeki MD, MPH, MPP, FAAP
Influenza Tim Uyeki MD, MPH, MPP, FAAP Influenza Division National Center for Immunization and Respiratory Diseases Coordinating Center for Infectious Diseases Centers for Disease Control and Prevention
E E Hepatitis E SARS 29, Lancet. E A B Enterically-Transmitted Non-A, Hepatitis E. Virus HEV nm. 1.35g/cm s ALT AST HEV HEV
7850 2004 Hepatitis E Tian-Cheng LI Naokazu TAKEDA Tatsuo MIYAMURA SARS 8 Lancet E E E Hepatitis E VirusHEV E E HEV HEV E 1955 29,000 E E A A B Enterically-Transmitted Non-A, Non-B Hepatitis 1983 Balayan
VACCINE ENGINEERING Dr.T.V.Rao MD
VACCINE ENGINEERING Dr.T.V.Rao MD DR.T.V.RAO MD 1 HISTORICAL PICTURE OF VACCINATION DR.T.V.RAO MD 2 WHAT IS A VACCINE A vaccine is any preparation intended to produce immunity to a disease by stimulating
10/6/2014. INFLUENZA: Why Should We Take The Vaccine? OUTLINE INFLUNZA VIRUS INFLUENZA VIRUS INFLUENZA VIRUS
INFLUENZA: Why Should We Take The Vaccine? Baptist Hospital Baptist Children s Hospital Doctors Hospital J. Milton Gaviria, MD, FACP October 17, 2014 Homestead Hospital Mariners Hospital Baptist Cardiac
Recombinant influenza vaccine
Engineering Conferences International ECI Digital Archives Vaccine Technology IV Proceedings Spring 5-21-2012 Recombinant influenza vaccine Manon Cox Protein Sciences Corporation Follow this and additional
Preparing for the Fall Flu Season. Jonathan Gubbay Medical Microbiologist Public Health Laboratory OAHPP
Preparing for the Fall Flu Season Laboratory Perspective Jonathan Gubbay Medical Microbiologist Public Health Laboratory OAHPP September 21, 2009 Objectives 1. Review the emergence of Novel Influenza A
2.1 VIRUSES. 2.1 Learning Goals
2.1 VIRUSES 2.1 Learning Goals To understand the structure, function, and how Viruses replicate To understand the difference between Viruses to Prokaryotes and Eukaryotes; namely that viruses are not classified
Education , Doctor of Philosophy, Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida Ongoing
AMIR SARAYANI Cell Phone: +1 (352) 222 4660 Mailing address: 1225 Center Drive, HPNP 2314, Gainesville, FL 32610 E-mail: sarayani@ufl.edu Curriculum Vitae Education 2017-2021, Doctor of Philosophy, Pharmaceutical
2009 (Pandemic) H1N1 Influenza Virus
2009 (Pandemic) H1N1 Influenza Virus September 15, 2009 Olympia, Washington Anthony A Marfin Washington State Department of Health Goals Understand current situation & pattern of transmission of 2009 H1N1
Jamshid Khoubi Curriculum vitae 2016
Jamshid Khoubi Curriculum vitae 2016 First name: Jamshid Last name: Khoubi Sex: Male Nationality: Iranian Date/place of birth: 1981/ Maragheh, East Azarbayjan, Iran Institutional address: Lecturer at health
Manitoba Influenza Surveillance Report
Manitoba Influenza Surveillance Report 2012/2013 Season Week 14 Mar 31 Apr 6, 2013 Mar 31 - Apr 6: The proportion of patients visiting sentinel physicians for influenza-likeillness was 11% (up from 0%
KAVEH HARATIAN PhD, Medical Virology, Iran University of Medical Sciences. Prof. Mahmoud Shamsi Shahrabadi
Kaveh Haratian 1 KAVEH HARATIAN astrokaveh@gmail.com EDUCATION 2001 07 PhD, Medical Virology, Iran University of Medical Sciences Thesis: Supervisor: Study of Inhibitory Effect of Buthionine Sulfoximine
Pandemic Influenza influenza epidemic: realization of a worst-case scenario
Pandemic Influenza October 9, 2006 1918 influenza epidemic: realization of a worst-case scenario First case: Albert Mitchell, Camp Funston, KS, March 11, 1918 Up to 20% of all humans infected 20-50 million
In the name of God CURRICULUM VITAE
In the name of God CURRICULUM VITAE PERSONAL DETAIL Name: Date of Birth: Mahdi Fazlalipour Sep 8, 1982 Place of Birth: Iran Gender: Male Nationality: Iranian Native Language: Persian Marital Status: Single
REVIEW Cell-mediated Immunity to Influenza Virus Infections: From the Perspective to the Vaccine Development against Highly Pathogenic Avian Influenza
JARQ 42 (4), 245 249 (2008) http://www.jircas.affrc.go.jp REVIEW : From the Perspective to the Vaccine Development against Highly Pathogenic Avian Influenza Hirokazu HIKONO 1 *, Masaji MASE 2, Satoko WATANABE
Development of a Novel Recombinant Influenza Vaccine in Insect Cells
Development of a Novel Recombinant Influenza Vaccine in Insect Cells Clifton McPherson New Cells for New Vaccines II September 18, 2007 cmcpherson@proteinsciences.com New Cell for New Vaccines II Topics:
1918 Influenza; Influenza A, H1N1. Basic agent information. Section I- Infectious Agent. Section II- Dissemination
1918 Influenza; Influenza A, H1N1 Basic agent information Section I- Infectious Agent Risk Group: - RG3 Synonym or Cross reference: - Spanish Flu - 1918 Flu - El Grippe Characteristics: - SELECT AGENT
Vahid Baniasadi Professional Experience 2015-Present: 2015-Present: 2015-Present: 2015-Present: 2014-Present: : Contact Information
Vahid Baniasadi Professional Experience 2015-Present: Head of International Affairs Office, Pasteur Institute of Iran. 2015-Present: Head of Public Relations Office, Pasteur Institute of Iran. 2015-Present:
Biomedical Engineering for Global Health. Lecture 9 Vaccine development: from idea to product
Biomedical Engineering for Global Health Lecture 9 Vaccine development: from idea to product Review of lecture 8 Pathogens: Bacteria and Virus Levels of Immunity: Barriers First line of defense Innate
What is Influenza? Patricia Daly MD, FRCPC Medical Health Officer and Medical Director of Communicable Disease Control
Vancouver Coastal Health & The Vancouver Coastal Health Research Institute presents: On Call with VGH Experts Lecture Series The Flu and You What is Influenza? Patricia Daly MD, FRCPC Medical Health Officer
Australian National Influenza Centres Activity
Australian National Influenza Centres Activity 2011-12 Professor Dominic Dwyer Medical Virologist Director ICPMR and WHO NIC Westmead Hospital Sydney, NSW 2145, Australia dominic.dwyer@sydney.edu.au WHO
INFLUENZA VIRUS. INFLUENZA VIRUS CDC WEBSITE
INFLUENZA VIRUS INFLUENZA VIRUS CDC WEBSITE http://www.cdc.gov/ncidod/diseases/flu/fluinfo.htm 1 THE IMPACT OF INFLUENZA Deaths: PANDEMICS 1918-19 S p a n is h flu 5 0 0,0 0 0 U S 2 0,0 0 0,0 0 0 w o rld
1) understand the structure and life cycle of viruses as well as viral evolution. 2) know the mechanisms of host immune responses to viral infections
VIROLOGY A The course aims to provide the student with the cognitive and methodological tools necessary to: 1) understand the structure and life cycle of viruses as well as viral evolution 2) know the
Foot and Mouth Disease Vaccine Research and Development in India
Foot and Mouth Disease Vaccine Research and Development in India R.Venkataramanan Indian Veterinary Research Institute, Hebbal, Bangalore 560 024 Foot and Mouth Disease in India Present Status Large Susceptible
Viral Antigens Recombinant Proteins. Life Science, Inc. Large Scale Manufacturing, R&D and Custom Services.
Viral Antigens Recombinant Proteins Large Scale Manufacturing, R&D and Custom Services Life Science, Inc. www.meridianlifescience.com Life Science, Inc. Meridian Life Science, (MLS) is an industry leader
Immunogenicity and Efflcacy of Baculovirus Derived Glycoprotein D of Herpes Simplex Virus Type-l in Mice
Arch. Raz; Ins. 55 (2003) 19-28 19 Immunogenicity and Efflcacy of Baculovirus Derived Glycoprotein D of Herpes Simplex Virus Type-l in Mice Soleimanjahi, H., Roostaee, M.H., Rassaee, M.J., Mahboodi, F.
Application of Reverse Genetics to Influenza Vaccine Development
NIAID Application of Reverse Genetics to Influenza Vaccine Development Kanta Subbarao Laboratory of Infectious Diseases NIAID, NIH Licensed Vaccines for Influenza Principle: Induction of a protective
Gene Vaccine Dr. Sina Soleimani
Gene Vaccine Dr. Sina Soleimani Human Viral Vaccines Quality Control Laboratory (HVVQC) Titles 1. A short Introduction of Vaccine History 2. First Lineage of Vaccines 3. Second Lineage of Vaccines 3. New
CURRICULUM VITAE. Name: Sepha Nyatichi Mabeya Place of Birth: Nyamira. Marital Status: Married. Education Background
CURRICULUM VITAE SEPHA NYATICHI MABEYA Jomo Kenyatta University of Agriculture & Technology School of Biomedical Sciences Department of Medical Microbiology P.O Box 62000 00200 Nairobi Mobile: (254) 0722